Photo from fda.gov
Mar 26, 2024, 19:09
FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products – FDA Oncology
FDA Oncology shared on X/Twitter:
“FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products.”
Further details.
Source: FDA Oncology/X
Jul 26, 2024, 08:02